MONOCLONAL ANTIBODIES: TX Rep. Chip Roy On Biden Admin Limiting This SUCCESSFUL TREATMENT
September 16, 2021
1,028
72
11
8.07%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dana Loesch Episodes Around September 16, 2021
See what was published immediately before and after this episode.
13:02Now PlayingMONOCLONAL ANTIBODIES: TX Rep. Chip Roy On Biden Admin Limiting This SUCCESSFUL TREATMENT
YouTube Description
as posted by the channelDana (@DLoesch) talks with TX Rep. Chip Roy (@chiproytx) (TX-21) on how and why the Biden administration is limiting the distribution (and it’s NOT an issue of supply) of Regeneron, a successful monoclonal antibodies treatment that has PROVEN to significantly reduce severe symptoms, hospitalization and death from COVID. It makes NO SENSE to limit this successful COVID treatment, while simultaneously MANDATING an experimental vaccine. Texas is expecting a ‘response’ from HHS on the Biden administration’s decision to limit the Regeneron doses to Texas by tomorrow (Friday) - and Chip Roy isn’t exactly confident that Texas will get any meaningful answers from this overreaching Democrat administration.
The overrun southern border - flooding with fentanyl and illegal immigrants (RECORD numbers) - is discussed.
Broadcast terrestrially coast to coast, stream, podcasted, one of the top 10 radio programs in the nation. Listen to Dana LIVE weekdays
Subscribe to the Chapter and Verse newsletter
Twitter: @DLoesch
Parler: @DanaLoesch
FB: @OfficialDanaLoesch
Instagram: @DLoesch
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.